Introduction: Hormonal therapy in endometrial cancer (EC) is used for patients who wish to
preserve fertility and for patients with advanced or recurrent disease in a palliative setting …

Objectives. The objectives of this study were to estimate the clinical response rate and
toxicity of daily tamoxifen combined with intermittent weekly medroxyprogesterone acetate …

PURPOSE Progestins represent the most widely used form of endocrine therapy in
advanced or recurrent endometrial carcinoma. Based on encouraging response rates in …

Background Endometrial cancer is a cancer of the lining of the womb and worldwide is the
seventh most common cancer in women. Treatment with hormones is thought to be …

BACKGROUND: Granulosa cell tumors of the ovary are rare, primarily treated surgically. In
advanced or recurrent disease, data are inconclusive regarding the benefit of either primary …

Progesterone (Pg) and estrogen (E) receptors (PgRs and ERs) are expressed in normal and
neoplastic adrenal cortex, but their role is not fully understood. In literature, Pg demonstrated …

Hormonal therapy of endometrial cancer - ScienceDirect Skip to main contentSkip to article
Elsevier logo Journals & Books Search RegisterSign in View PDF Download full issue …

Abstract Learning Objectives After completing this course, the reader will be able to: Discuss
the role of radiation therapy for advanced stage endometrial cancer in order to differentiate …

The “gold standard” treatment for endometrial cancer is completely staged surgery, followed
by radiation or chemotherapy, based on the final pathological surgical stage and …

With endometrial adenocarcinoma, several factors, such as stage and histologic grade, are
well recognized as having prognostic significance. Other variables, eg, nuclear grade …